Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00917618

Ligand	Ligand name	Chain	PDB	Tanimoto
D1R	NALPHA-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]-N-{(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}-L-PHENYLALANINAMIDE	A	2P7U	0.71
D1R	NALPHA-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]-N-{(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}-L-PHENYLALANINAMIDE	A,C	2OZ2	0.71
OIR	N-(3-PHENYL-2-SULFANYLPROPANOYL)PHENYLALANYLALANINE	A	1R1J	0.72
PG1	PENICILLIN G ACYL-SERINE	A,B	1XA7	0.7
PG1	PENICILLIN G ACYL-SERINE	A	2IWC	0.7
PG1	PENICILLIN G ACYL-SERINE	A,B	1MWT	0.7
B30	{2,2'-[(2-{[4-(AMINOSULFONYL)BENZOYL]AMINO}ETHYL)IMINO]DIACETATO(2-)-KAPPAO}COPPER	A	2FOV	0.71
B30	{2,2'-[(2-{[4-(AMINOSULFONYL)BENZOYL]AMINO}ETHYL)IMINO]DIACETATO(2-)-KAPPAO}COPPER	A,B	2FOY	0.71
OAP	4-(S)-[(1-OXO-7-PHENYLHEPTYL)AMINO]-5-[4-(PHENYLMETHYL)PHENYLTHIO]PENTANOIC ACID	A,B,C,D,E,F	1KVO	0.72
MQQ	N-[(1S)-1-[({(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}AMINO)CARBONYL]-3-(PHENYLSULFONYL)PROPYL]MORPHOLINE-4-CARBOXAMIDE	A	2G6D	0.72
IBG	GAMMA-GLUTAMYL[S-(2-IODOBENZYL)CYSTEINYL]GLYCINE	A	1M9B	0.71
GBI	S-(3-IODOBENZYL)GLUTATHIONE	A	2GSQ	0.71
PNM	OPEN FORM - PENICILLIN G	A	1GHP	0.71
PNM	OPEN FORM - PENICILLIN G	A	1PWC	0.71
PNM	OPEN FORM - PENICILLIN G	A	1IYQ	0.71
PNM	OPEN FORM - PENICILLIN G	A	1FQG	0.71
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2J8Y	0.71
PNM	OPEN FORM - PENICILLIN G	A,B,C,D	2JBF	0.71
PNM	OPEN FORM - PENICILLIN G	A	2EX8	0.71
M25	N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	A,B	2NMX	0.77
M25	N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	A	2NNS	0.77
BDL	N-(biphenyl-4-ylsulfonyl)-D-leucine	A	3EHX	0.7
4MC	(Z)-N-(5-GUANIDINO-1-OXO-1-(5-PHENYL-1-(PHENYLSULFONYL)PENT-1-EN-3-YLAMINO)PENTAN-2-YL)-4-METHYLPIPERAZINE-1-CARBOXAMIDE	A,C	2EFM	0.71
SOX	N-[(2S,4S,6R)-2-(DIHYDROXYMETHYL)-4-HYDROXY-3,3-DIMETHYL-7-OXO-4LAMBDA~4~-THIA-1-AZABICYCLO[3.2.0]HEPT-6-YL]-2-PHENYLACETAMIDE	B	1GM8	0.7
SOX	N-[(2S,4S,6R)-2-(DIHYDROXYMETHYL)-4-HYDROXY-3,3-DIMETHYL-7-OXO-4LAMBDA~4~-THIA-1-AZABICYCLO[3.2.0]HEPT-6-YL]-2-PHENYLACETAMIDE	A,B	1GM9	0.7
C1P	N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~-[(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP-2-ENYL]-D-LEUCINAMIDE	A,B,C,D	3BWK	0.73
C1P	N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~-[(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP-2-ENYL]-D-LEUCINAMIDE	A,B	1NPZ	0.73
GSB	S-BENZYL-GLUTATHIONE	A,B,C,D	1FRO	0.73
GSB	S-BENZYL-GLUTATHIONE	A,B,C,D	1GUH	0.73
JT5	N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide	A	2JT5	0.71
B15	[2,2'-({4-[({2-[4-(AMINOSULFONYL)PHENYL]ETHYL}AMINO)CARBONYL]BENZYL}IMINO)DIACETATO(2-)-KAPPAO]COPPER	A	2FOQ	0.71
BCS	BENZYLCYSTEINE	A,B,G,H	10GS	0.72
BCS	BENZYLCYSTEINE	A	1EH8	0.72
3CC	N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide	A	2QO8	0.74
GGC	1-MENAPHTHYL GLUTATHIONE CONJUGATE	A,B	3LJR	0.71